Stanford deploys 37,000 AI agents to create a virtual biotech
Rather than using AI as a single tool for a defined research task, the approach organises specialised agents into a structure that mirrors a biotechnology company.
Credit: WhiteMocca/Shutterstock
A Stanford research team has built a multi-agent AI system that can analyse tens of thousands of clinical trials and investigate potential therapeutic strategies, offering a glimpse of how agentic AI could reshape computational drug discovery
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
